Neuroprotective effects of FK-506 in rat stroke model not mediated by suppression of NO production Feb. 9, 1999
Clot-dissolving drug significantly improves disability outcome in phase III stroke trial Feb. 9, 1999
Ex vivo studies explain disappointing results with antiadhesion therapy in stroke patients Feb. 8, 1999
Second-generation NNRTIs show promising resistance profile, pharmacokinetics in preclinical studies Feb. 8, 1999
AIDS conference serves as forum for highlighting new Vertex/Glaxo Wellcome HIV protease inhibitor Feb. 5, 1999
RSS